QLI - Qilian International Corp Company Value to Earnings Growth Ratio

Qilian International (QLI) generates revenue through the wholesale supply of plant extracts and the sale of pharmaceuticals via its own pharmacies. The average peg_co level reflects the market valuation of earnings, with the parameter stabilizing at 0.00. Rising demand for natural remedies in China is driving the business, while the implementation of AI-controlled robotic extraction lines is significantly optimizing the company's production processes.

The PEG ratio serves as a critical filter for identifying undervalued assets by correlating the P/E multiple with earnings growth rates. When analyzing the current P/E-to-growth dynamics, it is essential to consider that for Qilian International (QLI), limited plant scalability and raw material dependency may artificially depress this metric, creating an illusion of cheapness despite a factual lack of levers to accelerate expansion.